Possibilities of preclinical diagnosis of anthracycline cardiotoxicity using the technique of "speckle-tracking echocardiography"

Abstract

In case of antitumour anthracyclines therapy of patients with non-Hodgkin lymphomas the possibility of using speckle-tracking echocardiography is being considered. It was found that patients with non-Hodgkin lymphomas have early violations of the left ventricular myocardium during the course of antitumor chemotherapy using anthracyclines. They are characterized by reducing of longitudinal deformation of the myocardium with a gradual spread from the apical to the basal segments of the left ventricle. A statistically significant reduction in global and segmental systolic deformation after the 4th course of chemotherapy (cumulative dose of doxorubicin 333.5 ± 88.5 mg/m²) is the earliest marker of left ventricular mechanical dysfunction, appearing before the development of diastolic dysfunction and ejection fraction reduction of the left ventricular. Early violations of myocardial mechanics in the dynamics of the course of antitumour therapy with anthracyclines are identified in the apical area of the left ventricle, it can be connected with circulatory failure in this area. Violations of myocardial mechanics in the apical area of the left ventricle can be an erly predictor of ischemia of this area with possible progression to global contractile muscle dysfunction of the left ventricular. The global longitudinall deformation of the left ventricular myocardium in contrast to ejection fraction of the left ventricular is more sensitive to myocardial damages against the backdrop of chemotherapy using anthracyclines. So, it can be used as an early preclinical marker of myocardial damage, that takes echocardiography closer to the most advanced methods of myocardial visualization.

Keywords

anthracyclines / doxorubicin / myocardial deformation / cardiotoxicity / left ventricle / non-Hodgkin’s lymphoma / speckle tracking echocardiography / echocardiography

References

[1] Abid S, Lipskaia L. Anthracycline cardiotoxicity: looking for new therapeutic approaches targeting cell senescence? Cardiovascular research. 2018;114(10):1304–1305.

[2] Abid S., Lipskaia L. Anthracycline cardiotoxicity: looking for new therapeutic approaches targeting cell senescence? // Cardiovascular research. 2018. Vol. 114, No. 10. P. 1304–1305.

[3] Golubtsov OU, Tyrenko VV, Polyakov AS, et al. Prospects of antioxidant therapy in prevention of cardiotoxicity caused by the use of antracycline antibiotics. Bulletin of Pirogov Nationale Medical Surgical Center. 2017;12(2):121–125. (In Russ.)

[4] Голубцов О.Ю., Тыренко В.В., Поляков А.С., и др. Перспективы использования антиоксидантов в профилактике кардиотоксичности, вызванной применением антрациклиновых антибиотиков // Вестн. Нац. мед.-хир. центра им. Н.И. Пирогова. 2017. Т. 12, № 2. С. 121–125.

[5] Awadalla M., Hassan M.Z. Advanced imaging modalities to detect cardiotoxicity. Current problems in cancer. 2018;42(4):386–396.

[6] Awadalla M., Hassan M.Z. Advanced imaging modalities to detect cardiotoxicity // Current problems in cancer. 2018. Vol. 42, No. 4. P. 386–396.

[7] Larsen CM, Mulvagh SL. Cardio-oncology: what you need to know now for clinical practice and echocardiography. Echo research and practice. 2017;4(1):33–41.

[8] Larsen C.M., Mulvagh S.L. Cardio-oncology: what you need to know now for clinical practice and echocardiography // Echo research and practice. 2017. Vol. 4, No. 1. P. 33–41.

[9] Thavendiranathan P, Grant AD. Reproducibility o echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J. Am. Coll. Cardiol. 2013;61:77–84.

[10] Thavendiranathan P., Grant A.D. Reproducibility o echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy // J. Am. Coll. Cardiol. 2013. Vol. 61. P. 77–84.

[11] Mele D, Rizzo P, Pollina AV. Cancer therapy-induced cardiotoxicity: role of ultrasound deformation imaging as an aid to early diagnosis. Ultrasound in medicine & biology. 2015;41(3):627–643.

[12] Mele D., Rizzo P., Pollina AV. Cancer therapy-induced cardiotoxicity: role of ultrasound deformation imaging as an aid to early diagnosis // Ultrasound in medicine & biology. 2015. Vol. 41, No. 3. P. 627–643.

[13] Blessberger H, Binder T. NON-invasive imaging: two dimensional speckle tracking echocardiography: basic principles. Heart. 2010;96 (9):716–722.

[14] Blessberger H., Binder T. NON-invasive imaging: two dimensional speckle tracking echocardiography: basic principles // Heart. 2010. Vol. 96, No. 9. P. 716–722.

[15] Dandel M, Lehmkuhl H, Knosalla C. Strain and strain rate imaging by echocardiography – basic concepts and clinical applicability. Curr. Cardiol. Rev. 2009;5(2):133–148.

[16] Dandel M., Lehmkuhl H., Knosalla C. Strain and strain rate imaging by echocardiography – basic concepts and clinical applicability // Curr. Cardiol. Rev. 2009. Vol. 5, No. 2. P. 133–148.

[17] Dalen H. Segmental and global longitudinal strain and strain rate based on echocardiography of 1266 healthy individuals: the Hunt study in Norway Eur. J. Echocardiogr. 2010;11(2):176–183.

[18] Dalen H. Segmental and global longitudinal strain and strain rate based on echocardiography of 1266 healthy individuals: the Hunt study in Norway Eur // J. Echocardiogr. 2010. Vol. 11, No. 2. P. 176–183.

[19] Geerts L, Bovendeerd P, Nicolay K. Characterization of the normal cardiac myofiber field in goat measured with MR-diffusion tensor imaging. Am J Physiol Heart Circ Physiol. 2002;283:139–145.

[20] Geerts L., Bovendeerd P., Nicolay K. Characterization of the normal cardiac myofiber field in goat measured with MR-diffusion tensor imaging // Am J Physiol Heart Circ Physiol. 2002. Vol. 283. P. 139–145.

[21] Hsu EW, Henriquez CS. Myocardial fiber orientation mapping using reduced encoding diffusion tensor imaging. J. Cardiovasc. Magn. Reson. 2001;3:339–347.

[22] Hsu E.W., Henriquez C.S. Myocardial fiber orientation mapping using reduced encoding diffusion tensor imaging // J. Cardiovasc. Magn. Reson. 2001. Vol. 3. P. 339–347.

[23] Sengupta PP, Khandheria BK, Korinek J. Biphasic tissue Doppler waveforms during isovolumic phases are associated with asynchronous deformation of subendocardial and subepicardial layers. J. Appl. Physiol. 2005;99:1104–1111.

[24] Sengupta P.P., Khandheria B.K., Korinek J. Biphasic tissue Doppler waveforms during isovolumic phases are associated with asynchronous deformation of subendocardial and subepicardial layers // J. Appl. Physiol. 2005. Vol. 99. P. 1104–1111.

[25] Nesser HJ, Mor-Avi V, Gorissen W. Quantification of left ventricular volumes using three–dimensional echocardiographic speckle tracking: comparison with MRI. Eur. Heart J. 2009;30(13):1565–1573.

[26] Nesser H.J., Mor-Avi V., Gorissen W. Quantification of left ventricular volumes using three-dimensional echocardiographic speckle tracking: comparison with MRI // Eur. Heart J. 2009. Vol. 30, No. 13. P. 1565–1573.

[27] Blessberger H, Binder T. NON-invasive imaging: two dimensional speckle tracking echocardiography: basic principles. Heart. 2010;96(9):716–722.

[28] Blessberger H., Binder T. NON-invasive imaging: two dimensional speckle tracking echocardiography: basic principles // Heart. 2010. Vol. 96, No. 9. P. 716–722.

[29] Dandel M, Lehmkuhl H, Knosalla C. Strain and strain rate imaging by echocardiography – basic concepts and clinical applicability. Curr. Cardiol. Rev. 2009;5(2):133–148.

[30] Dandel, M. Lehmkuhl H., Knosalla C. Strain and strain rate imaging by echocardiography – basic concepts and clinical applicability // Curr. Cardiol. Rev. 2009. Vol. 5, No. 2. P. 133–148.

[31] Geyer H, Caracciolo G, Abe H. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J. Am. Soc. Echocardiogr. 2010;23(4):351–369.

[32] Geyer H., Caracciolo G., Abe H. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications // J. Am. Soc. Echocardiogr. 2010. Vol. 23, No. 4. P. 351–369.

[33] Brown J, Jenkins C, Marwick TH. Use of myocardial strain to assess global left ventricular function: a comparison with cardiac magnetic resonance and 3-dimensional echocardiography. Am. Heart J. 2009;157(1):101–105.

[34] Brown J., Jenkins C., Marwick T.H. Use of myocardial strain to assess global left ventricular function: a comparison with cardiac magnetic resonance and 3-dimensional echocardiography // Am. Heart J. 2009. Vol. 157, No. 1. P. 101–105.

[35] Sun JP, Popovic ZB, Rovner A. Noninvasive quantification of regional myocardial function using ultrasonic strain, strain rate, velocity, and displacement in healthy subjects: effects of aging. J. Am. Soc. Echocardiogr. 2004;17:132–138.

[36] Sun J.P., Popovic Z.B., Rovner A. Noninvasive quantification of regional myocardial function using ultrasonic strain, strain rate, velocity, and displacement in healthy subjects: effects of aging // J. Am. Soc. Echocardiogr. 2004. Vol. 17. P. 132–138.

[37] Plana JC, Galderisi M, Barac A. Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15(10):1063–1093.

[38] Plana J.C., Galderisi M., Barac A. Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging // Eur Heart J Cardiovasc Imaging. 2014. Vol. 15, No. 10. P. 1063–1093.

RIGHTS & PERMISSIONS

Kryukov E.V., Golubtsov O.Y., Tyrenko V.V., Semelev V.N., Makiev R.G.